These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
209 related articles for article (PubMed ID: 29445125)
1. Pin1 impairs microRNA biogenesis by mediating conformation change of XPO5 in hepatocellular carcinoma. Li J; Pu W; Sun HL; Zhou JK; Fan X; Zheng Y; He J; Liu X; Xia Z; Liu L; Wei YQ; Peng Y Cell Death Differ; 2018 Sep; 25(9):1612-1624. PubMed ID: 29445125 [TBL] [Abstract][Full Text] [Related]
2. Targeting Pin1 by inhibitor API-1 regulates microRNA biogenesis and suppresses hepatocellular carcinoma development. Pu W; Li J; Zheng Y; Shen X; Fan X; Zhou JK; He J; Deng Y; Liu X; Wang C; Yang S; Chen Q; Liu L; Zhang G; Wei YQ; Peng Y Hepatology; 2018 Aug; 68(2):547-560. PubMed ID: 29381806 [TBL] [Abstract][Full Text] [Related]
3. Discovery of 4,6-bis(benzyloxy)-3-phenylbenzofuran as a novel Pin1 inhibitor to suppress hepatocellular carcinoma via upregulating microRNA biogenesis. Fan X; He H; Li J; Luo G; Zheng Y; Zhou JK; He J; Pu W; Zhao Y Bioorg Med Chem; 2019 Jun; 27(11):2235-2244. PubMed ID: 31027708 [TBL] [Abstract][Full Text] [Related]
4. The Role of Exportin-5 in MicroRNA Biogenesis and Cancer. Wu K; He J; Pu W; Peng Y Genomics Proteomics Bioinformatics; 2018 Apr; 16(2):120-126. PubMed ID: 29723684 [TBL] [Abstract][Full Text] [Related]
5. ERK Activation Globally Downregulates miRNAs through Phosphorylating Exportin-5. Sun HL; Cui R; Zhou J; Teng KY; Hsiao YH; Nakanishi K; Fassan M; Luo Z; Shi G; Tili E; Kutay H; Lovat F; Vicentini C; Huang HL; Wang SW; Kim T; Zanesi N; Jeon YJ; Lee TJ; Guh JH; Hung MC; Ghoshal K; Teng CM; Peng Y; Croce CM Cancer Cell; 2016 Nov; 30(5):723-736. PubMed ID: 27846390 [TBL] [Abstract][Full Text] [Related]
6. MicroRNA Biogenesis is Enhanced by Liposome-Encapsulated Pin1 Inhibitor in Hepatocellular Carcinoma. Sun D; Tan S; Xiong Y; Pu W; Li J; Wei W; Huang C; Wei YQ; Peng Y Theranostics; 2019; 9(16):4704-4716. PubMed ID: 31367251 [TBL] [Abstract][Full Text] [Related]
7. Discovery of a Prenylated Flavonol Derivative as a Pin1 Inhibitor to Suppress Hepatocellular Carcinoma by Modulating MicroRNA Biogenesis. Zheng Y; Pu W; Li J; Shen X; Zhou Q; Fan X; Yang SY; Yu Y; Chen Q; Wang C; Wu X; Peng Y Chem Asian J; 2019 Jan; 14(1):130-134. PubMed ID: 30474357 [TBL] [Abstract][Full Text] [Related]
8. miR-874-3p is down-regulated in hepatocellular carcinoma and negatively regulates PIN1 expression. Leong KW; Cheng CW; Wong CM; Ng IO; Kwong YL; Tse E Oncotarget; 2017 Feb; 8(7):11343-11355. PubMed ID: 28076852 [TBL] [Abstract][Full Text] [Related]
9. MicroRNA-140-5p inhibits hepatocellular carcinoma by directly targeting the unique isomerase Pin1 to block multiple cancer-driving pathways. Yan X; Zhu Z; Xu S; Yang LN; Liao XH; Zheng M; Yang D; Wang J; Chen D; Wang L; Liu X; Liu J; Chen RH; Zhou XZ; Lu KP; Liu H Sci Rep; 2017 Apr; 7():45915. PubMed ID: 28383568 [TBL] [Abstract][Full Text] [Related]
10. Understanding the role of PIN1 in hepatocellular carcinoma. Cheng CW; Leong KW; Tse E World J Gastroenterol; 2016 Dec; 22(45):9921-9932. PubMed ID: 28018099 [TBL] [Abstract][Full Text] [Related]
11. Regulation of XPO5 phosphorylation by PP2A in hepatocellular carcinoma. Li J; Zhou JK; Mu X; Shen S; Xu X; Luo Y; Luo Y; Ming Y; Wu Y; Peng Y MedComm (2020); 2022 Jun; 3(2):e125. PubMed ID: 35441157 [TBL] [Abstract][Full Text] [Related]
12. Inhibition of the prolyl isomerase Pin1 enhances the ability of sorafenib to induce cell death and inhibit tumor growth in hepatocellular carcinoma. Zheng M; Xu H; Liao XH; Chen CP; Zhang AL; Lu W; Wang L; Yang D; Wang J; Liu H; Zhou XZ; Lu KP Oncotarget; 2017 May; 8(18):29771-29784. PubMed ID: 28404959 [TBL] [Abstract][Full Text] [Related]
13. Downregulation and tumor-suppressive role of XPO5 in hepatocellular carcinoma. Li Y; Wang X; He B; Cai H; Gao Y Mol Cell Biochem; 2016 Apr; 415(1-2):197-205. PubMed ID: 27000860 [TBL] [Abstract][Full Text] [Related]
14. Pin1 interacts with a specific serine-proline motif of hepatitis B virus X-protein to enhance hepatocarcinogenesis. Pang R; Lee TK; Poon RT; Fan ST; Wong KB; Kwong YL; Tse E Gastroenterology; 2007 Mar; 132(3):1088-103. PubMed ID: 17383430 [TBL] [Abstract][Full Text] [Related]
15. PIN1 inhibits apoptosis in hepatocellular carcinoma through modulation of the antiapoptotic function of survivin. Cheng CW; Chow AK; Pang R; Fok EW; Kwong YL; Tse E Am J Pathol; 2013 Mar; 182(3):765-75. PubMed ID: 23333752 [TBL] [Abstract][Full Text] [Related]
16. PIN1 in hepatocellular carcinoma is associated with TP53 gene status. Bae JS; Noh SJ; Kim KM; Jang KY; Park HS; Chung MJ; Park BH; Moon WS Oncol Rep; 2016 Oct; 36(4):2405-11. PubMed ID: 27499097 [TBL] [Abstract][Full Text] [Related]
17. Pin1 inhibition reverses the acquired resistance of human hepatocellular carcinoma cells to Regorafenib via the Gli1/Snail/E-cadherin pathway. Wang J; Zhang N; Han Q; Lu W; Wang L; Yang D; Zheng M; Zhang Z; Liu H; Lee TH; Zhou XZ; Lu KP Cancer Lett; 2019 Mar; 444():82-93. PubMed ID: 30583078 [TBL] [Abstract][Full Text] [Related]
18. Mutant p53 Gains Its Function via c-Myc Activation upon CDK4 Phosphorylation at Serine 249 and Consequent PIN1 Binding. Liao P; Zeng SX; Zhou X; Chen T; Zhou F; Cao B; Jung JH; Del Sal G; Luo S; Lu H Mol Cell; 2017 Dec; 68(6):1134-1146.e6. PubMed ID: 29225033 [TBL] [Abstract][Full Text] [Related]
19. Chemical or genetic Pin1 inhibition exerts potent anticancer activity against hepatocellular carcinoma by blocking multiple cancer-driving pathways. Liao XH; Zhang AL; Zheng M; Li MQ; Chen CP; Xu H; Chu QS; Yang D; Lu W; Tsai TF; Liu H; Zhou XZ; Lu KP Sci Rep; 2017 Mar; 7():43639. PubMed ID: 28262728 [TBL] [Abstract][Full Text] [Related]
20. The role of Pin1 in the development and treatment of cancer. Min SH; Zhou XZ; Lu KP Arch Pharm Res; 2016 Dec; 39(12):1609-1620. PubMed ID: 27572155 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]